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 Patent ductus arteriosus is a congenital    
disorder in neonates in which the vessel 
fails to close after birth and remains patent 
or open (Jinmiao, Jing, Qin, & Zhiping, 
2017). 
 Delayed closure of ductus arteriosus (PDA) 
in preterm infants under 28 weeks is 
associated with high incidence of pulmonary 
hemorrhage, intraventricular hemorrhage 
(IVH), necrotizing enterocolitis (NEC), 
chronic lung disease and high mortality 
(Bhat & Das, 2015).
 Therefore, closure of the PDA is essential to 
prevent these complications and to improve 
both cardiorespiratory status and survival 
rate (El-Mashad, El-Mahdy, El Amrousy, 
Elgendy, & El-Mashad, 2017). 
 Initially indomethacin was the drug of choice 
for treating PDA; however it can affect renal, 
gastrointestinal and cerebral organs.  These 
complications can lead to transient or 
permanent renal dysfunctions, necrotizing 
enterocolitis, gastrointestinal hemorrhage 
and reduced cerebral intracellular 
oxygenation (Yang et al., 2013). 
 Ibuprofen was introduced and approved by 
the FDA as an alternative agent in April 
2006 for closure of PDA in premature infants 
(Yang, Song & Choi 2013).
METHODOLOGY
RESEARCH QUESTION LITERATURE SEARCH FLOW 
DIAGRAM
LITERATURE SYNTHESIS
 Ibuprofen was found to as effective as 
indomethacin for successful treatment of PDA 
closure.  This was noted by Ohlsson et al.,  El-
Mashad et al.,  ElHassan et al., Chan et al.,  
Pacifici et al., Gulack et al.,  Loomba et al., 
Yang et al., (2015, 2017, 2014, 2014, 2014, 
2015, 2015, 2013).
 Ibuprofen had fewer side effects than 
indomethacin but showed to have significant 
increase in serum bilirubin levels (ElHassan et 
al., 2014). 
 Ohlsson et al., Malikiwi et al., ElHassan et al., 
Pacifici et al., Loomba et al., Yang et al., all 
found ibuprofen groups had lower creatinine 
levels and reduced risk of oliguria compared to 
those treated with indomethacin (2015, 2015, 
2014 ,2014, 2015, 2013).
 Ibuprofen groups did however have more 
pulmonary hypertension compared to those in 
the indomethacin group.  This was noted by 
Malikiwi et al., ElHassan et al., (2015, 2014). 
 Jinmiao et al., Mitra et al., found high dose 
oral ibuprofen was more effective in closure of 
PDA compared to IV ibuprofen and IV 
indomethacin, but more studies are needed to 
determine long term adverse effects (2017, 
2018).
CLINICAL IMPLICATIONS 
 Ibuprofen is shown to be as effective as 
indomethacin in treatment of PDA closure. 
 Ibuprofen does show to have fewer adverse 
effects although both medications do come 
with significant adverse effects.
CONCLUSION
 Results of this literature have shown 
ibuprofen is as effective as indomethacin in 
PDA closure.
 However the adverse effects have not been 
proven to be majorly different.  Further level 1 
evidence research is needed to determine 
the safest medication for treatment in PDA 
closure.
 An integrated review of the literature was 
conducted using the methodology described 
by Whittemore and Knafl (2005) and Brown 
(2018). 
 Cochrane, CINAHL, Medline Complete and 
Pub Med were searched using the following  
key terms “ibuprofen”, and “indomethacin”, 
and  “patent ductus arteriosus”.
 Search criteria was limited to “full text 
articles” between the years 2013-2018 for all 
databases. 
 Inclusion criteria included studies involving 
the evaluation of  the efficacy in closure of 
PDA using ibuprofen or indomethacin, 
adverse effects related to this treatment 
utilizing these medications, routes of 
administrations and dosages.
 The original search identified 70 articles.  
After screening the articles, 23 duplicate 
articles were removed, 1 article was not 
available in English, 1 article was not 
available in full text and 33 articles were 
excluded due to pertaining to surgical 
treatment or studying paractemol medication 
or not related to this research topic.
 Findings from the studies were synthesized 
for comparative analysis of results.
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 Seventy articles were initially identified; 
twelve included in final sample.
 Level of evidence rated using evidence 
pyramid published by Long & Gannaway
and Appraisal Guides by Brown (2015; 
2018).
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